GeneReach Biotechnology (ROCO:4171) Ending Cash Position : NT$110.3 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is GeneReach Biotechnology Ending Cash Position?

GeneReach Biotechnology's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$110.3 Mil.

GeneReach Biotechnology's quarterly Ending Cash Position declined from Jun. 2024 (NT$246.9 Mil) to Sep. 2024 (NT$167.6 Mil) and declined from Sep. 2024 (NT$167.6 Mil) to Dec. 2024 (NT$110.3 Mil).

GeneReach Biotechnology's annual Ending Cash Position declined from Dec. 2022 (NT$748.6 Mil) to Dec. 2023 (NT$216.8 Mil) and declined from Dec. 2023 (NT$216.8 Mil) to Dec. 2024 (NT$110.3 Mil).

GeneReach Biotechnology Ending Cash Position Historical Data

The historical data trend for GeneReach Biotechnology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneReach Biotechnology Ending Cash Position Chart

GeneReach Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

313.68

663.43

748.61

216.77

110.27

GeneReach Biotechnology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															216.77	270.16	246.86	167.56	110.27

GeneReach Biotechnology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GeneReach Biotechnology's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	216.772	+	-106.503
	=	110.3

GeneReach Biotechnology's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	167.555	+	-57.286
	=	110.3

GeneReach Biotechnology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GeneReach Biotechnology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneReach Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneReach Biotechnology Corp (ROCO:4171) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.19, Keyuan 2nd Road, Taichung, TWN, 407

Website

https://www.genereach.com

GeneReach Biotechnology Corp is a biotechnology company. The company develops, manufactures and markets products for applied nucleic acid detection technology. Its products are utilised for aquaculture, agriculture, food, companion animal, livestock and human health industries.

GeneReach Biotechnology Headlines

No Headlines